Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025231 | 12602523 | 1 | I | 20160620 | 0 | 20160727 | 20160727 | DIR | 0.00 | F | N | 0.00000 | 20160630 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025231 | 12602523 | 1 | PS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | Y | Y | 0 | 10 | MG | Q8H | ||||||
| 126025231 | 12602523 | 2 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Oral | 0 | 750 | MG | QD | ||||||||
| 126025231 | 12602523 | 4 | C | ASCORBIC ACID. | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 6 | C | ATOVAQUONE. | ATOVAQUONE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 10 | C | DOCUSATE | DOCUSATE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 12 | C | ENOXAPARIN | ENOXAPARIN | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 14 | C | EHTACRYNIC ACID | 2 | 0 | |||||||||||||
| 126025231 | 12602523 | 16 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 18 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 20 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 22 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 24 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 26 | C | POLYETHYLENE GLYCOL 3350. | POLYETHYLENE GLYCOL 3350 | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 28 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 30 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 32 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 | ||||||||||||
| 126025231 | 12602523 | 34 | C | VANCOMYCIN | VANCOMYCIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126025231 | 12602523 | 1 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126025231 | 12602523 | Electrocardiogram QT prolonged |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126025231 | 12602523 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126025231 | 12602523 | 1 | 20160615 | 0 |